Joy Liu
Gastroenterology · Chicago, ILNPI 1558742072
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,600 of the $8,162 with a category attached, or 68.6%. Ironwood Pharmaceuticals, Inc accounts for 82.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $7,021 and has fallen 95.7% since, to $299 in 2025.
Across 34 payments — averaging $240.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironwood Pharmaceuticals, Inc$7K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$532
- Enterra Medical, Inc.$247
- AbbVie$182
- Johnson & Johnson$127
- Janssen Scientific Affairs, LLC$111
- plus $208 from 5 others
Across 4 payments — averaging $13,274 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$53K
What the payments were for
- Consulting fees$5,60069%
- Travel & lodging$1,15414%
- Food & beverage$1,30916%
- Education$991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,162 in reported general payments places this provider in the 80th percentile of 787 gastroenterology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 124 | $92,853 |
| MotegrityPrucalopride Succinate | 55 | $55,863 |
| XifaxanRifaximin | 15 | $34,800 |
| TrulancePlecanatide | 12 | $11,314 |
| Dexlansoprazole DrDexlansoprazole | 13 | $5,771 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 46 | $2,716 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 88 | $1,630 |
| Lubiprostone | 12 | $1,214 |
| Omeprazole | 85 | $914 |
| Pantoprazole Sodium | 56 | $702 |
| Ondansetron OdtOndansetron | 62 | $630 |
| Cyproheptadine Hcl | 12 | $416 |
| Dicyclomine Hcl | 38 | $404 |
| Mirtazapine | 20 | $289 |
| Promethazine Hcl | 25 | $143 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $182 | $92,853124 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $38 | $55,86355 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $532 | $46,11427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 787 gastroenterology providers in Illinois.
Other gastroenterology in Chicago
- David RubinChicago$1.5M
- Stephen HanauerChicago$1.4M
- Steven FlammChicago$1.3M
- Darren BrennerChicago$1.1M
- Russell CohenChicago$690K
- Parambir DulaiChicago$668K
- Christopher ChapmanChicago$645K
- Saurabh KapurChicago$532K
- Ikuo HiranoChicago$457K
- Adam SteinChicago$438K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.